Summary Lymphostimulatory and delayed-type hypersensitivity (DTH) immune responses to a candidate antileprosy vaccine Mycobacterium habana have been quantified in inbred AKR mice. M. habana vaccine in three physical states, live, heat killed and ,),-irradiated, was given intradermally to separate groups of mice and after 28 days these mice were given subcutaneous challenge with heat-killed M. leprae and heat-killed M. habana in the left hind footpad. Live BeG vaccine alone and in combination with ,),-irradiated M. habana were also compared similarly. A sufficient degree of DTH response was generated in mice by M. habana vaccine in all physical forms against two challenge antigens (lepromin and habanin). The BeG combination with M. habana did not increase the DTH response indicating internal adjuvanticity endowed in M. habana. The active hypersensitivity of immunized mice was transferable to syngeneic mice by the transfer of sensitized cells from the donor to the recipient mice intravenously. M. leprae-infected Rhesus monkey PBMe have shown comparable stimulatory response with M. habana (sonicate), and M. leprae (sonicate) antigens. The possibility of developing M. habana as a candidate antileprosy vaccine is discussed.
In mycobacterial diseases, protective immunity is mediated through bacterial kill and/or modulation of the immune response which is essentially cell mediated with two basic cell types: the T-lymphocytes and macrophages interacting through cytokines. 1 , 2 The basis of in vivo and in vitro tests is to examine and measure the nature of the responses of these cells to the immunogens. The most commonly employed test is the delayed type of hypersensitivity response in the skin elicite d by an intradermal injection of the immunogen. The in vitro tests, measuring the T-cell immunity are lymphocyte proliferation test (LPT) and the leucocyte migration inhibition test (LMIT). LMIT measures the release of lymphokines from anti genically driven lymphocytes and LPT measures DNA synthesis in actively mUltiplying cells due to release of lymphostimulatory factor(s). The skin DTH response assesses the individuals ability to mobilize the immunocytes to the injection site of the antigen. The DTH response evaluated in the form of a footpad enlargement (FPE) after injection of the antigen in animals is a way to monitor the test and to prove the indirect efficacy of habana combines the useful traits of these mycobacteria and may suitably be developed as a vaccine against leprosy.
In this report we present the data of comparative evaluation of in vivo DTH response generated by M. habana and other vaccine(s) in mice and successful transfer of the active immune hypersensitivity through sensitized cells in syngeneic mice. The in vitro lympho stimulatory response of M. leprae sensitized monkey cells have also been studied against M. habana antigen(s).
Materials and methods

GROWTH AND PREPARATION OF IMMUNIZING ANTIGENS
My cobacterium habana (M. simiae serovar-l, TMC 5135) was obtained from the TMC collection centre Saranac Lake, New York. The strain of BCG (Madras) was procured from the Tuberculosis Research Centre, Madras and freeze-dried preparations of armadillo derived M. leprae were obtained through Dr R. J. W. Rees of the National Institute for Medical Research Mill Hill, London. Mycobacteria other than M. leprae were maintained separately on Lowenstein-Jensen medium and their bulk growth was obtained in Sautons liquid medium. A live culture of BCG was used as vaccine, while M. habana vaccine was treated by 'Y-irradiation of the culture at 300 Krads from a 60 cobalt source. M. habana was also used in live and heat-killed states for immunization. Freeze-dried M. leprae preparations was reconstituted in normal saline at the required concentration.
CHALLENGE ANTIGENS
Integral habanin was prepared from mid-log culture of M. habana by standard procedures as applied for the preparation of integral lepromin (WHO protocol). The Mitsuda lepromin was obtained through Professor Noordeen, Chief Medical Officer, WHO, Geneva.
DOSE OF VACCINE AND ANTIGENS
Mice were immunized i/d with 6·27 x 10 8 organisms (63'3 p.g protein/animal) of M. habana in either live, heat-killed or 'Y-irradiated states while the dose of BCG and M. leprae were 6·0 x 10 5 and 2·0 x 10 7 bacilli per animal respectively (recommended optimal doses). The challenge dose of each antigen (habanin and lepromin) was 3 x 10 7 bacilli per footpad.
THE EXPERIMENTAL ANIMALS
Inbred AKR mice maintained in the Institute's animal house were used. The animals were kept on a pellet diet of Hindustan Lever Ltd, with water ad libitum. They were divided in groups on a similar weight basis. All vaccinations were done intradermally on the back and 28 days postvaccination the animals were challenged with eliciting antigens in the hind feet. The footpad thickness was measured prior and after challenge with a Schnelltaster (made in Germany) and corrected footpad enlargements (FPE) were calculated according to Shepard's method. 4
ADOPTIVE TRANSFER OF IMMUNITY
Sensitized splenic cells from vaccinated mice were obtained by extirpation of the spleen and mincing and passing through a metal sieve. The method of Patel & Lefford 14 was followed with slight modifications. The viability of the cells was determined by staining with Trypan blue. 1 x 108 viable splenic cells obtained from actively sensitized (vaccinated) mice were given i/v to separate groups of syngeneic mice for passive sensitization. After 24 h these passively sensitized mice were given a SIC challenge in the hind footpad with homo and heterologous eliciting antigens and the FPE was measured as described earlier.
LYMPHOCYTE TRANSFORMATION TEST (L TT)
Peripheral blood mononuclear cells (PBMC) were separated from heparinized blood of normal (tuberculin and lepromin negative) and M. leprae infected Rhesus monkeys by density gradient centrifugation (Lymphoprep-Nyegard S.Co.OSLO, Norway). These cells were washed thrice and their viability was determined by staining with Trypan blue (93% viable). The cells were finally suspended at 2 x 10 6 cells/ml in RPMI-1640 supplemented with 10% foetal calf serum (GIBCO, Grand Island, New York, USA), glutamine and antibiotics (streptomycin 100 �g/m1, penicillin 100 units/ml and gentamycin 20 �g/m1) . 100 �l of this suspension were dispensed in each well giving a concentration of 2 Inc., Cambridge, Massachusetta, USA) using glass fibre filters (GF/C Whatman, England) and radioactivity was counted in a liquid Scintillation counter (LKB Finland) using a toluene based scintillation cocktail.
RESULTS
INDUCTION OF DTH RESPONSE BY DIFFERENT VACCINES
All the three preparations (live, heat killed, and 'Y-irradiated) of M. hahana live, BCG, heat killed M. leprae and live BCG+ 'Y-irradiated M. habana were tested for generation of DTH response against homologous and heterologous antigenic challenge. The data are presented in Figure 1 . Average FPE with homologous antigen-habanin are 28·33 ± 7·53; 31-43 ± 6·90 and 31·66 ± 7·30 respectively in three types of vaccinated animals. With lepromin the FPE response of these groups of animals were 26·67 ± 5,15, 26·66 ± 8·16 and 28·33 ± 7·53 respectively. In animals vaccinated with live BCG heat killed M. leprae and live BCG+ r-irradiated M. hahana the responses with habanin were 23·33 ± 5,16, 21·66 ± 4·08 and
... 28·33 ± 7·52 and with lepromin the responses were 23·33 ± 8,16, 23·33 ± 5,16, 26·66 ± 8·16 respectively. It is apparent that both the sensitins have generated sufficient degree of DTH response in vaccinated animals than unvaccinated controls. The combined vaccination of animals with BeG + M. hahana did not impart better DTH response than with either vaccine alone.
ADOPTIVE TRANSFER OF IMMUNITY THROUGH SENSITIZED CELLS
Sensitized splenic cells from mice vaccinated with ,),-irradiated M. hahana, heat-killed M. hahana and heat-killed M. Zeprae were transferred intravenously to normal syngeneic mice. After 24 hours of passive sensitization these groups of animals were challenged with homologous and heterologous antigens. The individual animal data are presented in Figure 1 . A considerably higher number of animals developed passive sensitiz a tion and had higher FPE values than the controls with both the sensitins (habaninllepromin). Gamma irradiated M. hahana group of passively sensitized animals had better response than other groups. The average FPE of respective groups was 23·33 ± 8,16, 20·00 ± 8·94 and 16·66 ± 8·16 with habanin challenge and 20·00 ± 8,94, 18·7 ± 8·99 and 20·00 ± 5·77 with lepromin challenge.
L YMPHOSTIMULATORY RESPONSE
It is evident that optimal dose PHA-P is IJ.tg/rnl since this dose has generated maximum response in normal as well as M. Zeprae sensitized monkeys. The other two doses of PHA-P (one less, other higher) have also responded well but less than the optimal dose of IJ.tg/rnl. The lymphostimulatory responses with leprosin and habanin have also indicated that 0·5J.tgl rnl dose of both the antigens are optimum. Habanin has generated the LP response closer to PHA-P where as homologous response with leprosin and habanin have also indicated that 0·5J.tg/ml dose of both the antigens are optimum. Habanin has generated the LP response closer to PHA-P where as homologous response with leprosin is of a lower order.
The delayed-type hypersensitivity response is one of the several parameters used to test the indirect efficacy of cell-mediated immunity (CMI) to candidate vaccines. The test is conducted by inoculating the vaccine strain intradermally in mice and challenging the vaccinated mice SIC in the footpad after 3-4 weeks with heat-killed M. leprae. The footpad enlargement (FPE) is measured after 24 and 48 hr of challenge. Sensitized PBMC either by production of disease and/or by artificial in vitro sensitization when allowed to react with the specific antigen(s) secrete lymphocyte stimulatory factor(s) which stimulate the sensitized cells to proliferate profusely. This cell division is measured in terms of DNA synthesis which increases many fold. This test is specific in recognizing the antigenic relatedness/similarity between species/strains. M. habana (M. simiae) an atypical mycobacterium, has afforded protection against M. leprae and M. tuberculosis infectious challenges: in mice. M. habana vaccine in all the physical states (i.e. live, heat-killed and -y-irradiated) was able to generate DTH response against the homologous antigen habanin and the heterologous antigen lepromin. The DTH responses stimulated by heat-killed and -y-irradiated M. habana were apparently better than that stimulated by live vaccine although there were no statistically significant differences. This finding correlates well with a similar findings with heat-killed M. leprae by Shepard et al. 16 This may possibly be due to exposure of other antigens normally at some inaccessible regions after gamma irradiation or heat treatment. The DTH response stimulated by live BCG was inferior to those stimulated by other vaccines, although a heat-killed preparation of BCG was not included. It has been proved beyond doubt by several investigators that killed BCG does not sensitize mice. 16 The combined vaccination with live BCG and -y-irradiated M. habana did not increase sensitization more than either vaccines alone, which may possibly be due to internal adjuvanticity in M. habana. In animals, heat-killed M. leprae in combination with BCG does not enhance sensitization, 17 , 1 8 although in contrast to this, BCG in combination with heat-killed M. leprae in man provides an adjuvant effect. 19.20 This property of M. habana and M. leprae seems to be similar in animals.
Data for humans in respect of M. habana vaccine are not available at present, which is in progress. Heat-killed M. leprae was a poor sensitizer of mice than M. habana in our hands, whether tested against habanin or lepromin. Like M. leprae (-y-irradiated), BCG and other candidate leprosy vaccines, M. habana also produces adoptive immunity which is transferable to syngeneic mice with actively sensitized cells.
M. habana antigen(s) have also stimulated strong lymphostimulatory responses, comparable to those stimulated by M. leprae antigen(s) in PBMC(s) from M. leprae sensitized Rhesus monkeys. This indicates sharing of common epitopes between these two mycobacteria.
Since M. habana possesses several immunogenic, it could be developed as a vaccine for the prophylaxis/immunotherapy of leprosy.
